Pharmaceutical Executive, Dec 1, 2012 - Pharmaceutical Executive

ADVERTISEMENT

Pharmaceutical Executive, Dec 1, 2012
Features
Transforming Drug Development: A Lilly–Covance Case Study
Eli Lilly's pioneering pact with leading CRO Covance made big news when it happened. Four years later, both parties can point to metrics that suggest the benefit is mutual.
Germany's Price Reform Revolution
At two years and counting, what's the secret of success in negotiating pricing under the new AMNOG legislation?
The Puzzle Master: EMA's Guido Rasi
By William Looney
Europe's chief regulator charts a strategy from many moving parts. Dr Guido Rasi talks to Pharm Exec's William Looney.
Column
Big Data, Bigger Ideas
How to stop worrying and learn to love the data.
Obamacare, Innovation and Pricing
By Jill Wechsler
Tax and budget decisions will shape the healthcare market and drug research and regulation.
Top Medical Innovations for 2013
By Ben Comer
Ben Comer profiles 10 innovative technologies designated as new and revolutionary tools for the treatment of disease and disability.
From the Editor
2012: Year of Record
By William Looney
The calendar says its wrap-up time, not just for gifts but for some of the trends that shaped the industry—for good or bad—in 2012.

ADVERTISEMENT

Click here